These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The use of macroarrays for the identification of MDR Mycobacterium tuberculosis. Brown TJ; Herrera-Leon L; Anthony RM; Drobniewski FA J Microbiol Methods; 2006 May; 65(2):294-300. PubMed ID: 16153726 [TBL] [Abstract][Full Text] [Related]
25. The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from Southern China. Tan Y; Hu Z; Zhao Y; Cai X; Luo C; Zou C; Liu X J Clin Microbiol; 2012 Jan; 50(1):81-5. PubMed ID: 22075601 [TBL] [Abstract][Full Text] [Related]
26. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation. Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194 [TBL] [Abstract][Full Text] [Related]
27. Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm. Simons SO; van der Laan T; Mulder A; van Ingen J; Rigouts L; Dekhuijzen PN; Boeree MJ; van Soolingen D Clin Microbiol Infect; 2014 Oct; 20(10):1015-20. PubMed ID: 24890253 [TBL] [Abstract][Full Text] [Related]
28. Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis. Srivastava K; Das R; Jakhmola P; Gupta P; Chauhan DS; Sharma VD; Singh HB; Sachan AS; Katoch VM Indian J Med Res; 2004 Aug; 120(2):100-5. PubMed ID: 15347859 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis. Brandis G; Pietsch F; Alemayehu R; Hughes D J Antimicrob Chemother; 2015 Mar; 70(3):680-5. PubMed ID: 25362573 [TBL] [Abstract][Full Text] [Related]
31. Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan. Farooqi JQ; Khan E; Alam SM; Ali A; Hasan Z; Hasan R J Pak Med Assoc; 2012 Aug; 62(8):767-72. PubMed ID: 23862246 [TBL] [Abstract][Full Text] [Related]
32. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France. Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O; Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222 [TBL] [Abstract][Full Text] [Related]
33. Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations. Abanda NN; Djieugoué JY; Khadka VS; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Deng Y; Eyangoh SI; Taylor DW; Leke RGF Clin Microbiol Infect; 2018 Jul; 24(7):781.e1-781.e3. PubMed ID: 29217277 [TBL] [Abstract][Full Text] [Related]
34. Drug-resistant strains of Mycobacterium tuberculosis isolated in Russia. Stepanshina VN; Panfertsev EA; Korobova OV; Shemyakin IG; Stepanshin YG; Medvedeva IM; Dorozhkova IR Int J Tuberc Lung Dis; 1999 Feb; 3(2):149-52. PubMed ID: 10091881 [TBL] [Abstract][Full Text] [Related]
35. Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India. Maurya AK; Singh AK; Kant S; Umrao J; Kumar M; Kushwaha RA; Nag VL; Dhole TN Indian J Med Microbiol; 2013; 31(3):230-6. PubMed ID: 23883707 [TBL] [Abstract][Full Text] [Related]
36. Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB). Cirillo DM; Piana F; Frisicale L; Quaranta M; Riccabone A; Penati V; Vaccarino P; Marchiaro G New Microbiol; 2004 Jul; 27(3):221-7. PubMed ID: 15460524 [TBL] [Abstract][Full Text] [Related]
37. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa. Evans J; Stead MC; Nicol MP; Segal H J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875 [TBL] [Abstract][Full Text] [Related]
38. Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK. Melzer M; Gupta N; Petersen I; Cook S; Hall B Int J Infect Dis; 2010 Aug; 14(8):e717-22. PubMed ID: 20542460 [TBL] [Abstract][Full Text] [Related]
39. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates. Mokrousov I; Bhanu NV; Suffys PN; Kadival GV; Yap SF; Cho SN; Jordaan AM; Narvskaya O; Singh UB; Gomes HM; Lee H; Kulkarni SP; Lim KC; Khan BK; van Soolingen D; Victor TC; Schouls LM J Microbiol Methods; 2004 Jun; 57(3):323-35. PubMed ID: 15134881 [TBL] [Abstract][Full Text] [Related]
40. The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Ahmad S; Mokaddas E Int J Antimicrob Agents; 2005 Sep; 26(3):205-12. PubMed ID: 16099622 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]